Clinical Cannabis for the Health Care Provider

Close up view of a neuron floating on a green background

The October 2019 Clinical Cannabis for the Health Care Provider CME course explored the pharmacology, uses, benefits and risks of clinical cannabis for patients.

Expert clinician scientists discussed the evidence for use of cannabis to manage chronic pain, pediatric epilepsy, and other disease states.

Presentations also addressed mechanisms of action, side effects, risks and access.

The event was well attended and hosted nine exhibitors. Attendees gave positive feedback, citing both the broadness of the presentation topics and the applicability to attendees’ medical practices and research.

Event archive

Learning objectives

After this symposium, attendees will be able to:

  • Describe the clinical pharmacology and pharmacodynamics of cannabis and its active components
  • Identify potential drug-drug interactions that may occur with cannabis use
  • Discuss potential medical uses of cannabis and cannabinoids for the treatment of chronic pain, multiple sclerosis spasticity and seizure disorders
  • Understand the potential adverse effects of cannabis
  • Understand special considerations for cannabis use in pregnant and lactating women
  • Be familiar with socioeconomic trends and influences in cannabis use


8 a.m.: Registration, continental breakfast and exhibits

8:30 a.m.: Welcome and introduction
Michelle Cameron, M.D., M.C.R., PT
Associate Professor, Department of Neurology, OHSU

9 a.m.: The pharmacology of cannabis
Joseph Bubalo, Pharm.D., BCPS, BCOP
Oncology Clinical Pharmacy Specialist, College of Pharmacy, OHSU

9:50 a.m.: Potential benefits in selected populations

  • Treatment of chronic pain
    Kim Jones, RNC, Ph.D., FNP., FAAN
    Dean and Professor, School of Nursing, Linfield College
  • Spasticity management in multiple sclerosis
    Michelle Cameron, M.D., M.C.R., PT
    Associate Professor, Department of Neurology, OHSU
  • Epilepsy, with a special focus on children
    Colin Roberts, M.D.
    Associate Professor, Department of Neurology, OHSU

11:10 a.m.: Potential adverse effects and risks in selected populations
Associate Professor, Department of Medical Informatics and Clinical Epidemiology, OHSU

  • Special considerations in pregnant and lactating women
    Jamie Lo, M.D.
    Assistant Professor, Department of Obstetrics and Gynecology, OHSU
    Affiliate Assistant Professor, Oregon National Primate Research Center, OHSU

Noon: Cannabis: A global, national, and local overview of socioeconomic trends
Beau Whitney, M.B.A.
Vice President and Senior Economist, New Frontier Data

12:30 p.m.: Wrap up – Q&A with faculty